Status:
COMPLETED
Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation
Lead Sponsor:
University of South Florida
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Metabolic Disorders
Eligibility:
All Genders
Brief Summary
The purpose of this study is to learn about the effects of long term carnitine use in patients with metabolic disorders and its potential relationship to cardiovascular events.
Detailed Description
This online cross-sectional survey will examine the self-reported long-term carnitine use in patients with metabolic disorders and any potential relationship to cardiovascular events.
Eligibility Criteria
Inclusion
- Diagnosis of mitochondrial disease or any other metabolic disorder
- Any age group
- NAMDC or RDCRN registry participant
Exclusion
- Inability to provide informed consent and complete survey
- Lack of participation in NAMDC or RDCRN registry
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT02311270
Start Date
September 1 2014
End Date
June 1 2016
Last Update
September 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of South Florida
Tampa, Florida, United States, 33612